POSTN and hepatocellular carcinoma: By using the αvβ3 receptor inhibitor cilengitide and the TGFβ1 inhibitor SB431542 at both the cellular level and in the PDX model in vivo, both inhibitors presented intense effects in reversing the POSTN-induced stemness transformation and malignant progression of HCC.